<DOC>
	<DOCNO>NCT01729169</DOCNO>
	<brief_summary>Diagnosing cardiac sarcoidosis always challenge : No single imaging modality prove effective cardiac biopsy low sensitivity . 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose ( FDG ) PET precede least 12 hour fast previously demonstrate reasonable accuracy , however , patient physiological FDG uptake cardiac region hamper correct identification sarcoid granuloma . Gallium Ga 68-DOTANOC conjugate somatostatin analogue Nal3-octreotide ( NOC ) gallium Ga 68-labeled 1,4,7,10-tetraazacyclododecane-N , N ' , N '' , N '' '-tetraacetic acid ( DOTA ) . We aim study whether 68Ga-DOTANOC superior sensitivity accuracy 18-FDG PET diagnose cardiac sarcoidosis . In addition , aim compare 18-FDG PET precede 12 hour fast 18-FDG PET somatostatin blockade insulin mediate cardiac glucose uptake .</brief_summary>
	<brief_title>Cardiac Sarcoidosis : FDG PET vs. Ga-DOTANOC PET</brief_title>
	<detailed_description>Intervention : - Study A : Subjects biopsy proven sarcoidosis suspect cardiac involvement ( prone arrhythmia , cardiac failure , unexplained dyspnea ) study twice : 1 ) 18-FDG PET precede 12 hour fast 2 ) 18-FDG PET perform 2 hour somatostatin blockade ( 300 microgram/hour ) /Heparin infusion . - Study B : Subjects biopsy proven sarcoidosis suspect cardiac involvement study twice : 1 ) 18-FDG PET precede 12 hour fast 2 ) 68Ga-DOTANOC PET precede least 6 hour fast .</detailed_description>
	<mesh_term>Sarcoidosis</mesh_term>
	<criteria>Biopsy proven sarcoidosis Suspected cardiac sarcoidosis Ischemic heart disease Diabetes Cardiomyopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Sarcoidosis</keyword>
	<keyword>Cardiac sarcoidosis</keyword>
	<keyword>18-FDG PET</keyword>
	<keyword>68Ga-DOTANOC PET</keyword>
</DOC>